Exact Mass: 219.1834

Allosedamine

(-)-Sedamine

5-HTQ

N,N,N-Trimethylserotonin

C13H19N2O (219.1497)

Miglustat

(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol

Miglustat is a drug used to treat Gaucher disease. It inhibits the enzyme glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids. It is only used for patients who cannot be treated with enzyme replacement therapy with imiglucerase. It is marketed under the trade name Zavesca. Miglustat is now the first and only approved therapy for patients with Niemann-Pick disease type C (NP-C). It has recently been approved for treatment of progressive neurological symptoms in adult and pediatric patients in the European Union, Brazil, and South Korea. A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AX - Various alimentary tract and metabolism products D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors C471 - Enzyme Inhibitor > C2846 - Glucosidase Inhibitor D004791 - Enzyme Inhibitors

1-hydroperoxy-8-carboxyoctyl-3,4-epoxynon-(2E)-enyl-ether

1-hydroperoxy-8-carboxyoctyl-3,4-epoxynon-(2E)-enyl-ether is considered to be practically insoluble (in water) and basic

Grotan

2-[3,5-bis(2-hydroxyethyl)-1,3,5-triazinan-1-yl]ethan-1-ol

C9H21N3O3 (219.1583)

3-(1-Propyl-3-piperidinyl)phenol

N-N-Propyl-3-(3-hydroxyphenyl)piperidine, S-(-)-isomer

D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

Cimaterol

2-amino-5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzonitrile

Lucerastat

1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol

Quinpirole

5-Propyl-1,4,4a,6,7,8,8a,9-octahydropyrazolo[3,4-g]quinoline

Cimaterol

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists CONFIDENCE standard compound; EAWAG_UCHEM_ID 3657

(-)-7-Demethyl-desoxynupharidin|(9aS)-4t-furan-3-yl-1c-methyl-(9ar)-octahydro-quinolizine

Decahydroquinoline, 2,5-diprop-2-enyl-

CHEMBL365496

2-Hydroxymethyl-5-(1-hydroxypentyl)-3,4-pyrrolidinediol

Hypusin

C9H21N3O3 (219.1583)

6-Ethoxy-2,3,4-trimethyl-1,2,3,4-tetrahydroquinoline

CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7195; ORIGINAL_PRECURSOR_SCAN_NO 7194 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7200; ORIGINAL_PRECURSOR_SCAN_NO 7199 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7217; ORIGINAL_PRECURSOR_SCAN_NO 7215 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7214; ORIGINAL_PRECURSOR_SCAN_NO 7212 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7230; ORIGINAL_PRECURSOR_SCAN_NO 7229 CONFIDENCE standard compound; INTERNAL_ID 1319; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7237; ORIGINAL_PRECURSOR_SCAN_NO 7236

Azoprocarbazine

(2R,5S)-2,5-diallyldecahydroquinoline

(2R,5R)-2,5-diallyldecahydroquinoline

(2R,5S,8aS)-2,5-diallyldecahydroquinoline

(2S,5S)-2,5-diallyldecahydroquinoline

2-(prop-2-yn-1-yl)-5-propyldecahydroquinoline

(5R,8R)-8-ethyl-5-(pent-4-yn-1-yl)octahydroindolizine

(5S,8R)-8-ethyl-5-(penta-2,4-dien-1-yl)octahydroindolizine

(5R,8R)-5-((E)-but-2-en-1-yl)-8-propyl-1,2,3,5,8,8a-hexahydroindolizine

(4R,6S)-4,6-diallyloctahydro-2H-quinolizine

miglustat

(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol

A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AX - Various alimentary tract and metabolism products D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors C471 - Enzyme Inhibitor > C2846 - Glucosidase Inhibitor D004791 - Enzyme Inhibitors

1,4,7,10-Tetraoxa-13-azacyclopentadecane

4-(4-propan-2-ylpiperazin-1-yl)aniline

pyrrolidin-1-yl(4,5,6,7-tetrahydro-3H-benzimidazol-5-yl)methanone

3-(4-Phenylpiperazin-1-yl)propan-1-amine

2-cyclohexylamino-1-phenylethanol

2-(1-BENZYL-PYRROLIDIN-3-YL)-PROPAN-2-OL

(S)-TERT-BUTYL (1,5-DIHYDROXYPENTAN-2-YL)CARBAMATE

(2-CYANO-PHENYL)-ACETICACIDETHYLESTER

1-METHYL-4-(PIPERIDIN-4-YL)PIPERAZINE HYDROCHLORIDE

C10H22ClN3 (219.1502)

1-(1-Adamantyl)pyrrolidin-2-one

(2-(PIPERIDIN-1-YLMETHYL)PHENYL)BORONIC ACID

(4-octylphenyl)methanamine

1-Phenyl-3-(1-piperazinyl)-1-propanamine

1-(PYRIDIN-3-YL)NONAN-1-ONE

1-(PYRIDIN-4-YL)NONAN-1-ONE

2-Decylpyridine

3-Decylpyridine

1-benzyl-piperidine-4-boronic acid

4-decylpyridine

N-BENZYL-4-(2-HYDROXYETHYL)PIPERIDINE

3-(4-TERT-BUTOXY-PHENYL)-PYRROLIDINE

2-Methylpyridine-5-boronic acid pinacol ester

CHEMBRDG-BB 4010741

2-Methylpyridine-3-boronic acid pinacol ester

6-Methylpyridine-2-boronic acid pinacol ester

Benzamide,4-methyl-N,N-bis(1-methylethyl)-

1-(PYRIDIN-2-YL)NONAN-1-ONE

4-METHYLPYRIDINE-2-BORONIC ACID PINACOL ESTER

4-(3-phenylpropyl)piperidin-4-ol

(S)-2-(1-Benzylpyrrolidin-2-yl)propan-2-ol

N-(2-Phenoxyethyl)cyclohexanamine

2-(4-o-Tolyl-piperazin-1-yl)ethylamine

2-Aminophenylboronic acid pinacol ester

5-Methylpyridine-2-boronic acid pinacol ester

N-(4-aminophenyl)-2-pyrrolidin-1-ylacetamide

(S)-5-METHOXY-N-PROPYL-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE

4-Nonylaniline

N-methyl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]methanamine

(-)-cis-2-benzylaminocyclohexanemethanol

4-(AMINOMETHYL)-4-P-TOLYLCYCLOHEXANOL

1H-Azepine,2-(2-ethoxyphenyl)hexahydro-(9CI)

2-PROPYLAMINO-5-METHOXYTETRALIN

2-(1-benzylpyrrolidin-2-yl)propan-2-ol

2-(4-methoxyphenyl)-5-methylazepane

2-PHENYL-3-PIPERIDIN-1-YL-PROPAN-1-OL

N-{3-[Dimethoxy(methyl)silyl]propyl}-1-butanamine

C10H25NO2Si (219.1654)

4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

Zylofuramine

PIPERIDINE-4-CARBOXYLIC ACID (4-METHYL-PYRIDIN-2-YL)-AMIDE

N-(5-methylpyridin-2-yl)piperidine-3-carboxamide

PIPERIDINE-3-CARBOXYLIC ACID (6-METHYL-PYRIDIN-2-YL)-AMIDE

Rimantadine-d4 hydrochloride

C12H18ClD4N (219.1692)

4-[(4-ethoxyphenyl)methyl]piperidine

N,N-DIBUTYL-M-TOLUIDINE

4-(4-hydroxypiperidin-1-yl)benzimidamide

(3R,3?)-ALL-TRANS-ASTAXANTHIN

C12H23F2N (219.1798)

2-(4-Methylpiperazin-1-ylmethyl)benzylamine

2-AMINO-5-(PIPERIDIN-1-YL)BENZAMIDE

4-[[di(propan-2-yl)amino]methyl]benzaldehyde

2-(4-phenylpiperazin-1-yl)acetamide

PIPERIDINE-4-CARBOXYLIC ACID (6-METHYL-PYRIDIN-2-YL)-AMIDE

PIPERIDINE-4-CARBOXYLIC ACID (5-METHYL-PYRIDIN-2-YL)-AMIDE

PIPERIDINE-3-CARBOXYLIC ACID (4-METHYL-PYRIDIN-2-YL)-AMIDE

[(1R,2S)-2-(Benzylamino)cyclohexyl]methanol

2-(4-HYDROXY-PIPERIDIN-1-YL)-BENZAMIDINE

N-cyclohexyl-4-ethoxyaniline

3-(2-propan-2-ylphenoxy)piperidine

(3-AMINOPHENYL)(4-METHYLPIPERAZIN-1-YL)METHANONE

4-(4-Ethylpiperazin-1-ylmethyl)phenylamine

8,8-Dimethyl-9-oxa-2-azaspiro[5.5]undecane hydrochloride (1:1)

C11H22ClNO (219.139)

3-(4-ACETYL-PIPERAZIN-1-YL)ANILINE

1-(4-(2-AMINOPHENYL)PIPERAZIN-1-YL)ETHANONE

2-[(diethylamino)methyl]cyclohexanone hydrochloride

C11H22ClNO (219.139)

CHEMBRDG-BB 4015547

4-Piperidinecarboxamide,4-(phenylamino)-

3-(4-Methylpiperazin-1-ylmethyl)benzylamine

(6-AMINOPYRIDIN-2-YL)(1-METHYLPIPERIDIN-4-YL)METHANONE

3-(1-Piperazinylmethyl)benzamide

3-(1-Pyrrolidinoethyl)phenylboronic acid

4-PIPERIDINOL, 3,3-DIMETHYL-1-(PHENYLMETHYL)-

2-(4-METHYLPIPERAZINYL)-1-PHENYLETHYLAMINE

N-BOC-2-AMINOMETHYL-BUTANE-1,4-DIOL

CHEMBRDG-BB 4010734

2-[(3-ethoxyphenyl)methyl]piperidine

4-Aminooctanophenone

5-amino-1,3-diethyl-6-methylbenzimidazol-2-one

N-(3-piperazin-1-ylphenyl)acetamide

3-Picoline-5-boronic acid pinacolate

(3,5-ditert-butylphenyl)methanamine

4-[(4-Methyl-1-piperazinyl)carbonyl]aniline

2-aminoethanol,7-methyloctanoic acid

C11H25NO3 (219.1834)

N-Methyl-1-(4-pentylphenyl)-2-propanamine

Quinoline, 4-ethoxy-1,2,3,4-tetrahydro-2,6,7-trimethyl- (9CI)

3-aminophenylboronic acid pinacol ester

3-[(4-ethoxyphenyl)methyl]piperidine

4-[2-(4-Methyl-1-piperazinyl)ethyl]aniline

2-Methylpyridine-4-boronic acid pinacol ester

4-(4-METHYL-1,4-DIAZEPAN-1-YL)BENZYLAMINE

1-Acetyl-4-(4-aminophenyl)piperazine

1-[4-(4-Aminophenyl)piperazin-1-yl]ethanone

3-Methylpyridine-4-boronic acid pinacol ester

2-(2-Hydroxyethylamino)-1,6,7-trimethylbenzimidazole

3-Butyl-1,2-dimethyl-1H-imidazol-3-ium dicyanoazanide

C11H17N5 (219.1484)

1H-Azepine-3-Methanol, hexahydro-1-(phenylMethyl)-

1-phenyl-3-piperidin-4-ylurea

3-(4-Phenyl-1-piperidinyl)-1-propanol

5-amino-2-piperidin-1-ylbenzamide

n-alpha-acetyl-l-lysine-n-methylamide monohydrate

C9H21N3O3 (219.1583)

1H-Azepine,2-(4-ethoxyphenyl)hexahydro-(9CI)

2-(3-Ethoxyphenyl)azepane

2-(3,4-DIMETHYL-PHENYL)-AZEPANE

1-(2-aminoethyl)-4-benzylpiperazine

6-n-hexylaminopurine

C11H17N5 (219.1484)

N-[(4-ethylphenyl)methyl]-1-(oxolan-2-yl)methanamine

n-(pyridin-2-ylmethyl)piperidine-4-carboxamide

1-BENZYL-PYRROLIDINE-3-CARBOXYLIC ACID HYDRAZINE

[4-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]METHYLAMINE

ZERENEX ZX007740

2-(2-phenylethyl)-1,3,6,2-dioxazaborocane

N,N-dimethyl-4-(piperazin-1-ylmethyl)aniline

1-(4-CHLORO-2-NITROPHENYL)-3-METHYLPIPERAZINE HYDROCHLORIDE

1-(4-Aminophenyl)-N,N-dimethyl-4-piperidinamine

Lucerastat

C471 - Enzyme Inhibitor Lucerastat, the galactose form of Miglustat, is an orally-available inhibitor of glucosylceramide synthase (GCS). Lucerastat has the potential for Fabry disease study[1][2].

Quinpirole

D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

Hexen

Cinobufotenine

C13H19N2O+ (219.1497)

D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

4-(2-Aminoethyl)-2-cyclohexylphenol

497-88-1

(1S)-2-[(2S)-1-methylpiperidin-2-yl]-1-phenyl-ethanol

8-Phenyloctanoate

C14H19O2- (219.1385)

N-(2-carboxyethyl)spermidine

C10H25N3O2+2 (219.1947)

4-hydroxy-N,N,N-trimethyltryptamine

C13H19N2O+ (219.1497)

Lycopodane

2,6,9-Trimethyl-13-oxatetracyclo[6.3.1.1(6,9).0(1,5)]tridecane carbocation

C15H23O+ (219.1749)

(-)-Sedamine

3-(1-Propyl-3-piperidinyl)phenol

D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

5-Propyl-1,4,4a,6,7,8,8a,9-octahydropyrazolo[3,4-g]quinoline

5-HTQ

N,N,N-Trimethylserotonin

C13H19N2O+ (219.1497)

D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

(R)-Preclamol

(R)-Preclamol is a dopamine (DA) agonist with autoreceptor as well as postsynaptic receptor stimulatory properties. (R)-Preclamol inhibits the locomotor activity of mice and rats in low doses[1].

(2s,2's)-sedamine

{"Ingredient_id": "HBIN006613","Ingredient_name": "(2s,2's)-sedamine","Alias": "NA","Ingredient_formula": "C14H21NO","Ingredient_Smile": "CN1CCCCC1CC(C2=CC=CC=C2)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "19632","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

6-c-butyl-dmdp